Hegseth Is Pushing Testosterone. The VA Has Already Struggled With the Treatment.
Secretary Pete Hegseth has proposed annual testosterone screening for service members aged 30 and older, with optional screening for younger troops. Critics warn that the initiative could lead to overprescription, fertility reductions, and long‑term dependency on hormone therapy. The Department of Veterans Affairs has previously struggled with managing testosterone treatment, raising concerns about continuity of care for veterans.
- ▪The proposal calls for routine testosterone tests for service members 30 and older regardless of symptoms.
- ▪Medical experts say testosterone therapy can suppress natural hormone production and reduce sperm counts, creating dependency.
- ▪A 2018 VA Inspector General review found many patients started on testosterone without documented symptoms or proper follow‑up.
- ▪Guidelines require repeated low testosterone readings and clinical symptoms before treatment, which the VA has often failed to meet.
The Intercept files mainly under politics. We currently carry 59 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Intercept |
| Canonical URL | https://theintercept.com/2026/07/24/hegseth-testosterone-hormone-therapy-veterans-affairs/ |
| Publication time | Fri, 24 Jul 2026 14:25:58 +0000 |
| Retrieval time | 2026-07-24T14:34:47.661Z |
| Last seen | 2026-07-24T14:34:47.661Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | Et_JFRmyHTyo |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Hegseth Is Pushing Testosterone. The VA Has Already Struggled With the Treatment. “Men who take testosterone will have a reduction in their sperm counts,” one medical professor said. There’s no stated plan for continuing care. Austin Campbell July 24 2026, 10:25 a.m. ET Share Copy link Share on Facebook Share on Bluesky Share on X Share on LinkedIn Share on WhatsApp Pete Hegseth during a Senate Appropriations Committee hearing in Washington, D.C., on July 21, 2026. Photo: Tierney L.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Intercept.
Discussion
0 commentsMore from The Intercept
